Researchers examined rates of HAIs caused by C. diff and multidrug-resistant organisms in six Norfolk, Va.-based Sentara Healthcare hospitals. They studied and compared the HAI rates in three parallel intervention periods of 90, 180 and 240 days as well as three before and after periods. The intervention involved replacing all the regular non-biocidal linens with the copper oxide-impregnated biocidal linens.
While comparing the three before periods with the three after periods, researchers found:
• A 61.2 percent drop in C. diff-linked HAIs per 10,000 patient-days between the first before and after period
• A 41.1 percent drop between the second before and after period
• A 42.9 percent drop between the third before and after period
Additionally, researchers found:
• A 48.3 percent drop in multidrug-resistant organism-linked HAIs per 10,000 patient-days between the first before and after period
• A 36.4 percent drop between the second before and after period
• A 19.2 percent drop between the third before and after period
More articles on healthcare quality:
How EMR interventions helped Boston Medical Center cut unneeded testing
‘Major infection control deficiencies’ identified after infant’s death at New Jersey hospital
Only 37% of adults got flu shot last year, says CDC
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
